Human Immunodeficiency Virus Type 1 Vaccine Development: Recent Advances in the Cytotoxic T-Lymphocyte Platform “Spotty Business”

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Journal of Virology

• Publication date

  2007-11-07

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/JVI.01634-07PMID 17989174PMCID PMC2268479
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Intradermal/subcutaneous immunization by electroporation improves plasmid vaccine delivery and potency in pigs and rhesus macaques.

  2008cited by this paper
• Combined effects of IL-12 and electroporation enhances the potency of DNA vaccination in macaques.

  2008cited by this paper
• Protection against simian/human immunodeficiency virus (SHIV) 89.6P in macaques after coimmunization with SHIV antigen and IL-15 plasmid

  2007cited by this paper
• Comparative ability of plasmid IL-12 and IL-15 to enhance cellular and humoral immune responses elicited by a SIVgag plasmid DNA vaccine and alter disease progression following SHIV(89.6P) challenge in rhesus macaques.

  2007cited by this paper
• Intramuscular rather than oral administration of replication-defective adenoviral vaccine vector induces specific CD8+ T cell responses in the gut.

  2007cited by this paper
• Ability of herpes simplex virus vectors to boost immune responses to DNA vectors and to protect against challenge by simian immunodeficiency virus.

  2007cited by this paper
• Effect of Preexisting Immunity to Adenovirus Human Serotype 5 Antigens on the Immune Responses of Nonhuman Primates to Vaccine Regimens Based on Human- or Chimpanzee-Derived Adenovirus Vectors

  2007cited by this paper
• Effect of Plasmid DNA Vaccine Design and In Vivo Electroporation on the Resulting Vaccine-Specific Immune Responses in Rhesus Macaques

  2007cited by this paper
• A Phase 1/2 Comparative Vaccine Trial of the Safety and Immunogenicity of a CRF01_AE (Subtype E) Candidate Vaccine: ALVAC-HIV (vCP1521) Prime With Oligomeric gp160 (92TH023/LAI-DID) or Bivalent gp120 (CM235/SF2) Boost

  2007cited by this paper
• Multiple immunizations with adenovirus and MVA vectors improve CD8+ T cell functionality and mucosal homing.

  2007cited by this paper
• Chemical adjuvants for plasmid DNA vaccines.

  2007cited by this paper
• Lessons From a Multisite International Trial in the Caribbean and South America of an HIV-1 Canarypox Vaccine (ALVAC-HIV vCP1452) With or Without Boosting With MN rgp120

  2007cited by this paper
• Recombinant modified vaccinia virus Ankara provides durable protection against disease caused by an immunodeficiency virus as well as long-term immunity to an orthopoxvirus in a non-human primate.

  2007cited by this paper
• What next? Newspaper Article.

  2007cited by this paper
• Comparative Seroprevalence and Immunogenicity of Six Rare Serotype Recombinant Adenovirus Vaccine Vectors from Subgroups B and D

  2007influential reference
• Questions Remain on Cause of Death in Arthritis Trial

  2007cited by this paper
• Neurovirulence properties of recombinant vesicular stomatitis virus vectors in non-human primates

  2006cited by this paper
• Relative contributions of codon usage, promoter efficiency and leader sequence to the antigen expression and immunogenicity of HIV-1 Env DNA vaccine.

  2006cited by this paper
• Multimeric Soluble CD40 Ligand and GITR Ligand as Adjuvants for Human Immunodeficiency Virus DNA Vaccines

  2006cited by this paper
• Immunity's yin and yang. A successful vaccine must first avoid being eliminated by pre-existing immunity before it can promote a protective immune response.

  2006cited by this paper
• Characterization of Immune Responses Elicited in Macaques Immunized Sequentially with Chimeric VEE/SIN Alphavirus Replicon Particles Expressing SIVGag and/or HIVEnv and with Recombinant HIVgp140Env Protein

  2006cited by this paper
• Vaccination preserves CD4 memory T cells during acute simian immunodeficiency virus challenge

  2006cited by this paper
• In Vivo Electroporation for Gene Therapy

  2006cited by this paper
• Hexon-chimaeric adenovirus serotype 5 vectors circumvent pre-existing anti-vector immunity

  2006cited by this paper
• Preserved CD4+ Central Memory T Cells and Survival in Vaccinated SIV-Challenged Monkeys

  2006cited by this paper
• Antibody Responses against HIV in Rhesus Macaques following Combinations of Mucosal and Systemic Immunizations with Chimeric Alphavirus-Based Replicon Particles

  2006cited by this paper
• DNA vaccines for HIV: challenges and opportunities

  2006cited by this paper
• Phase 1 clinical trials of the National Institutes of Health Vaccine Research Center HIV/AIDS candidate vaccines.

  2006cited by this paper
• Improved Vaccine Protection from Simian AIDS by the Addition of Nonstructural Simian Immunodeficiency Virus Genes1

  2006cited by this paper
• Mechanisms of Gastrointestinal CD4+ T-Cell Depletion during Acuteand Early Human Immunodeficiency Virus Type 1 Infection

  2006cited by this paper
• Systemic Immunization with an ALVAC-HIV-1/Protein Boost Vaccine Strategy Protects Rhesus Macaques from CD4+ T-Cell Loss and Reduces both Systemic and Mucosal Simian-Human Immunodeficiency Virus SHIVKU2 RNA Levels

  2006cited by this paper
• Potent immunogenicity of an HIV-1 gag-pol fusion DNA vaccine delivered by in vivo electroporation.

  2006cited by this paper
• Excellent Safety and Tolerability of the Human Immunodeficiency Virus Type 1 pGA2/JS2 Plasmid DNA Priming Vector Vaccine in HIV Type 1 Uninfected Adults

  2006cited by this paper
• Macaque Multimeric Soluble CD40 Ligand and GITR Ligand Constructs Are Immunostimulatory Molecules In Vitro

  2006cited by this paper
• A dose sparing effect by plasmid encoded IL-12 adjuvant on a SIVgag-plasmid DNA vaccine in rhesus macaques.

  2006influential reference
• Immunogenicity of Heterologous Recombinant Adenovirus Prime-Boost Vaccine Regimens Is Enhanced by Circumventing Vector Cross-Reactivity

  2006cited by this paper
• Combination DNA plus protein HIV vaccines

  2006cited by this paper
• A DNA prime-oral Listeria boost vaccine in rhesus macaques induces a SIV-specific CD8 T cell mucosal response characterized by high levels of alpha4beta7 integrin and an effector memory phenotype.

  2006cited by this paper
• Innate immune responses: crosstalk of signaling and regulation of gene transcription.

  2006cited by this paper
• Phase 1 safety and immunogenicity evaluation of a multiclade HIV-1 candidate vaccine delivered by a replication-defective recombinant adenovirus vector.

  2006cited by this paper
• Phase 1 safety and immunogenicity evaluation of a multiclade HIV-1 DNA candidate vaccine.

  2006cited by this paper
• Viral vectors for malaria vaccine development

  2006cited by this paper
• SIV DNA vaccine co‐administered with IL‐12 expression plasmid enhances CD8 SIV cellular immune responses in cynomolgus macaques

  2005cited by this paper
• Peak SIV replication in resting memory CD4+ T cells depletes gut lamina propria CD4+ T cells

  2005cited by this paper
• Polyvalent DNA prime and envelope protein boost HIV‐1 vaccine elicits humoral and cellular responses and controls plasma viremia in rhesus macaques following rectal challenge with an R5 SHIV isolate

  2005cited by this paper
• Vectored Gag and Env but Not Tat Show Efficacy against Simian-Human Immunodeficiency Virus 89.6P Challenge in Mamu-A*01-Negative Rhesus Monkeys

  2005cited by this paper
• Attenuation of Simian Immunodeficiency Virus SIVmac239 Infection by Prophylactic Immunization with DNA and Recombinant Adenoviral Vaccine Vectors Expressing Gag

  2005cited by this paper
• Cytotoxic T-Lymphocyte Escape Does Not Always Explain the Transient Control of Simian Immunodeficiency Virus SIVmac239 Viremia in Adenovirus-Boosted and DNA-Primed Mamu-A*01-Positive Rhesus Macaques

  2005cited by this paper
• Non-viral vector as vaccine carrier.

  2005cited by this paper
• Vaccination of macaques with SIV immunogens delivered by Venezuelan equine encephalitis virus replicon particle vectors followed by a mucosal challenge with SIVsmE660.

  2005cited by this paper
• Novel Adeno-Associated Virus Vector Vaccine Restricts Replication of Simian Immunodeficiency Virus in Macaques

  2005cited by this paper
• Adenovirus Vector-Based Vaccines for Human Immunodeficiency Virus Type 1

  2005cited by this paper
• Priming with Plasmid DNAs Expressing Interleukin-12 and Simian Immunodeficiency Virus Gag Enhances the Immunogenicity and Efficacy of an Experimental AIDS Vaccine Based on Recombinant Vesicular Stomatitis Virus

  2005cited by this paper
• Biodegradable mucoadhesive particulates for nasal and pulmonary antigen and DNA delivery.

  2005cited by this paper
• Vaccines with Enhanced Costimulation Maintain High Avidity Memory CTL1

  2005cited by this paper
• DNA prime Listeria boost induces a cellular immune response to SIV antigens in the rhesus macaque model that is capable of limited suppression of SIV239 viral replication.

  2005cited by this paper
• Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection

  2005cited by this paper
• Adenovirus types 5 and 35 seroprevalence in AIDS risk groups supports type 35 as a vaccine vector

  2004cited by this paper
• CD4+ T Cell Depletion during all Stages of HIV Disease Occurs Predominantly in the Gastrointestinal Tract

  2004cited by this paper
• Primary HIV-1 Infection Is Associated with Preferential Depletion of CD4+ T Lymphocytes from Effector Sites in the Gastrointestinal Tract

  2004cited by this paper
• Prevalence of Neutralizing Antibodies to Adenoviral Serotypes 5 and 35 in the Adult Populations of The Gambia, South Africa, and the United States

  2004cited by this paper
• Multiprotein HIV Type 1 Clade B DNA/MVA Vaccine: Construction, Safety, and Immunogenicity in Macaques

  2004cited by this paper
• Novel Replication-Incompetent Vector Derived from Adenovirus Type 11 (Ad11) for Vaccination and Gene Therapy: Low Seroprevalence and Non-Cross-Reactivity with Ad5

  2004cited by this paper
• Control of Simian/Human Immunodeficiency Virus Viremia and Disease Progression after IL-2-Augmented DNA-Modified Vaccinia Virus Ankara Nasal Vaccination in Nonhuman Primates1

  2004cited by this paper
• Neutralizing Antibodies and CD8+ T Lymphocytes both Contribute to Immunity to Adenovirus Serotype 5 Vaccine Vectors

  2004cited by this paper
• The ins and outs of transcriptional control: nucleocytoplasmic shuttling in development and disease.

  2004cited by this paper
• The evolution of HIV and its consequences.

  2004cited by this paper
• Immunogenicity of Recombinant Adenovirus Serotype 35 Vaccine in the Presence of Pre-Existing Anti-Ad5 Immunity1

  2004cited by this paper
• Immunogenicity of Attenuated Vesicular Stomatitis Virus Vectors Expressing HIV Type 1 Env and SIV Gag Proteins: Comparison of Intranasal and Intramuscular Vaccination Routes

  2004cited by this paper
• Recent advances in the development of HIV-1 vaccines using replication-incompetent adenovirus vectors.

  2004cited by this paper
• Enhanced Sensitivity of Detection of Cytotoxic T Lymphocyte Responses to HIV Type 1 Proteins Using an Extended In Vitro Stimulation Period for Measuring Effector Function in Volunteers Enrolled in an ALVAC-HIV Phase I/II Prime Boost Vaccine Trial in Thailand

  2004cited by this paper
• Bacteria-mediated DNA transfer in gene therapy and vaccination

  2004cited by this paper
• Molecular adjuvants for mucosal immunity

  2004cited by this paper
• Immune responses to adeno-associated virus and its recombinant vectors

  2003cited by this paper
• Immunogenicity of Multiple Gene and Clade Human Immunodeficiency Virus Type 1 DNA Vaccines

  2003cited by this paper
• Femtosecond infrared laser-an efficient and safe in vivo gene delivery system for prolonged expression.

  2003cited by this paper
• Alphavirus-based DNA vaccine breaks immunological tolerance by activating innate antiviral pathways

  2003cited by this paper
• Comparison of the CD8+ T cell responses and antitumor effects generated by DNA vaccine administered through gene gun, biojector, and syringe.

  2003cited by this paper
• Replication-Deficient Human Adenovirus Type 35 Vectors for Gene Transfer and Vaccination: Efficient Human Cell Infection and Bypass of Preexisting Adenovirus Immunity

  2003influential reference
• Severe CD4+ T-Cell Depletion in Gut Lymphoid Tissue during Primary Human Immunodeficiency Virus Type 1 Infection and Substantial Delay in Restoration following Highly Active Antiretroviral Therapy

  2003cited by this paper
• Microparticles as vaccine adjuvants and delivery systems

  2003cited by this paper
• Impact of clade diversity on HIV-1 virulence, antiretroviral drug sensitivity and drug resistance.

  2003cited by this paper
• Induction of CD8+ T Cells to an HIV-1 Antigen through a Prime Boost Regimen with Heterologous E1-Deleted Adenoviral Vaccine Carriers 1

  2003cited by this paper
• A Simian Replication-Defective Adenoviral Recombinant Vaccine to HIV-1 Gag 1

  2003cited by this paper
• Mucosal Priming of Simian Immunodeficiency Virus-Specific Cytotoxic T-Lymphocyte Responses in Rhesus Macaques by the Salmonella Type III Secretion Antigen Delivery System

  2003cited by this paper
• Alphavirus vectors and vaccination

  2002cited by this paper
• Adenovirus Hexon Protein Is a Potent Adjuvant for Activation of a Cellular Immune Response

  2002cited by this paper
• Hexon Gene Switch Strategy for the Generation of Chimeric Recombinant Adenovirus

  2002cited by this paper
• Modifications of the Human Immunodeficiency Virus Envelope Glycoprotein Enhance Immunogenicity for Genetic Immunization

  2002cited by this paper
• Engineered Listeria monocytogenes as an AIDS vaccine.

  2002cited by this paper
• Exosomes: composition, biogenesis and function

  2002cited by this paper
• Development of safe and efficient novel nonviral gene transfer using ultrasound: enhancement of transfection efficiency of naked plasmid DNA in skeletal muscle

  2002cited by this paper
• Electroporation improves the efficacy of DNA vaccines in large animals.

  2002cited by this paper
• Encapsulation of recombinant adenovirus into alginate microspheres circumvents vector-specific immune response

  2002cited by this paper
• Differential Induction of Mucosal and Systemic Antibody Responses in Women After Nasal, Rectal, or Vaginal Immunization: Influence of the Menstrual Cycle1

  2002cited by this paper
• PEGylation of E1-Deleted Adenovirus Vectors Allows Significant Gene Expression on Readministration to Liver

  2002cited by this paper
• Novel, Chimpanzee Serotype 68-Based Adenoviral Vaccine Carrier for Induction of Antibodies to a Transgene Product

  2002cited by this paper
• Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine.

  2002cited by this paper
• Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity

  2002cited by this paper
• Both Mucosal and Systemic Routes of Immunization with the Live, Attenuated NYVAC/Simian Immunodeficiency Virus SIVgpe Recombinant Vaccine Result in Gag-Specific CD8+ T-Cell Responses in Mucosal Tissues of Macaques

  2002cited by this paper

• Preventive HIV Vaccines-Leveraging on Lessons from the Past to Pave the Way Forward

  2021cites this paper
• Major Scientific Hurdles in HIV Vaccine Development: Historical Perspective and Future Directions

  2020cites this paper
• Propionibacterium acnes Enhances the Immunogenicity of HIVBr18 Human Immunodeficiency Virus-1 Vaccine

  2018cites this paper
• A brief history of the global effort to develop a preventive HIV vaccine.

  2013cites this paper
• 51 – Human immunodeficiency virus vaccines

  2013cites this paper
• Adenovirus type 35, but not type 5, stimulates NK cell activation via plasmacytoid dendritic cells and TLR9 signaling.

  2012cites this paper
• Generation of antigen-specific immunity following systemic immunization with DNA vaccine encoding CCL25 chemokine immunoadjuvant

  2012cites this paper
• Recent advances in antiretroviral treatment and prevention in HIV-infected patients.

  2011cites this paper
• Immune Modulation through 4-1BB Enhances SIV Vaccine Protection in Non-Human Primates against SIVmac251 Challenge

  2011cites this paper
• Induction of mucosal and systemic antibody and T-cell responses following prime–boost immunization with novel adjuvanted human immunodeficiency virus-1-vaccine formulations

  2011cites this paper
• Newcastle Disease Virus Expressing Human Immunodeficiency Virus Type 1 Envelope Glycoprotein Induces Strong Mucosal and Serum Antibody Responses in Guinea Pigs

  2011cites this paper
• Low cholesterol? Don't brag yet ... hypocholesterolemia blunts HAART effectiveness: a longitudinal study

  2010cites this paper
• Characterization of immune responses induced by combined clade-A HIV-1 recombinant adenovectors in mice.

  2010cites this paper
• HIV vaccine could use a little help

  2010cites this paper
• Plasmids encoding the mucosal chemokines CCL27 and CCL28 are effective adjuvants in eliciting antigen-specific immunity in vivo

  2010cites this paper
• Electroporation-Mediated DNA Vaccination

  2010cites this paper
• hypocholesterolemia blunts HAART effectiveness: a longitudinal study

  2010cites this paper
• Systemic immunization with CCL27/CTACK modulates immune responses at mucosal sites in mice and macaques.

  2010cites this paper
• Comparative ability of IL-12 and IL-28B to regulate Treg populations and enhance adaptive cellular immunity.

  2009cites this paper
• Plasmid-Encoded Interleukin-15 Receptor α Enhances Specific Immune Responses Induced by a DNA Vaccine In Vivo

  2009cites this paper
• Manipulation of TH17 responses in pulmonary immunity and disease through vaccination

  2009cites this paper
• Lentiviral Vector-Based Prime/Boost Vaccination against AIDS: Pilot Study Shows Protection against Simian Immunodeficiency Virus SIVmac251 Challenge in Macaques

  2009cites this paper
• Lentiviral vectors for HIV disease prevention and treatment.

  2009cites this paper
• Why we don't have an HIV vaccine, and how we can develop one.

  2009cites this paper
• A recombinant DNA and vaccinia virus prime–boost regimen induces potent long-term T-cell responses to HCV in BALB/c mice

  2009influential citation
• Special Topic: Progress and Challenges in Vaccinology HIV/AIDS Vaccines: A Need for New Concepts?

  2008cites this paper
• CD40L expressed from the canarypox vector, ALVAC, can boost immunogenicity of HIV-1 canarypox vaccine in mice and enhance the in vitro expansion of viral specific CD8+ T cell memory responses from HIV-1-infected and HIV-1-uninfected individuals.

  2008cites this paper
• HBsAg-vectored DNA vaccines elicit concomitant protective responses to multiple CTL epitopes relevant in human disease

  2008cites this paper
• DNA vaccines: developing new strategies to enhance immune responses

  2008cites this paper
• Immunogenicity of DNA and recombinant Sendai virus vaccines expressing the HIV-1 gag gene

  2008cites this paper
• Journal of Immune Based Therapies and Vaccines Prospects for Control of Emerging Infectious Diseases with Plasmid Dna Vaccines History of Dna Vaccines

  year unknowncites this paper